medigraphic.com
Colegio de Medicina Interna de México.

2025, Number S2

<< Back

Med Int Mex 2025; 41 (S2)

Efectos de la dieta cetogénica en la insuficiencia cardiaca con disfunción ventricular: una revisión de la evidencia reciente

Tirado HEE

Language: Spanish
References: 12
Page: S32-S34
PDF size: 257.78 Kb.


Text Extraction

No astract.


REFERENCES

  1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease andstroke statistics -2019 update: a report from the AmericanHeart Association. Circulation 2019; 139 (10): e56e528.https://doi.org/10.1161/CIR.0000000000000659

  2. Heidenreich PA, Albert NM, Allen LA, et al. Forecastingthe impact of heart failure in the United States: a policystatement from the American Heart Association. CircHeart Fail 2013; 6 (3): 606-619. https://doi.org/10.1161/HHF.0b013e318291329a

  3. Butler J, Fonarow GC, Greene SJ, et al. In hospital andpost-discharge heart failure management: outcomes andmedication use by race and ethnicity. JACC Heart Fail 2014;2 (5): 403-410.

  4. Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss:a review of the therapeutic uses of very-low-carbohydrate(ketogenic) diets. Eur J Clin Nutr 2013; 67 (8): 789-96.https://doi.org/10.1038/ejcn.2013.116

  5. Newman JC, Verdin E. β-hydroxybutyrate: much more thana metabolite. Diabetes Res Clin Pract 2014; 106 (2): 173-81.https://doi.org/10.1016/j.diabres.2014.08.009

  6. Volek JS, Phinney SD. The Art and Science of Low CarbohydratePerformance. Beyond Obesity LLC, 2012.

  7. Nielsen R, Moller N, Gormsen LC, et al. Cardiovascular effectsof ketone bodies in humans: a review. Am J PhysiolHeart Circ Physiol 2019; 316 (5): H1106-H1120. https://doi.org/10.1161/CIRCULATIONAHA.118.036459

  8. Dyck JR, Lopaschuk GD. Ketone bodies: a new energysource for the failing heart. Circulation 2018; 139 (4): 400-402. https://doi.org/10.1016/j.tem.2021.07.006

  9. Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketonesand the heart: metabolic principles and therapeuticimplications. Circ Res 2023; 132 (7): 882-98. https://doi.org/10.1161/CIRCRESAHA.123.321872

  10. Blake M, Puchalska P, Kazmirczak F, Blake J, et al. Ketonebodies in right ventricular failure: A unique therapeuticopportunity. Heliyon 2023; 9 (11): e22227. https://doi.org/10.1016/j.heliyon.2023.e22227

  11. Nachon García F, Saldaña-Davila G.E. Participation ofa low-fat controlled ketogenic diet in the regulation ofblood pressure in mexican women with type I. Obesity IntJ Diabetes Metabolic Synd 2024; 4 (1): 1-6.

  12. Nachón García F, Ochoa C, Saldaña-Davila GE, Nachón-Aguayo N. Effect of the very low calorie ketogenic low-fatdiet (VLCKLFD) compared to a low-calorie diet (LCD) onthe lipid profile of mexican patients with type I obesity.AHJ 2024; 267: 119-20




2020     |     www.medigraphic.com